HOME
ABOUT
LOG-IN
SEARCH BY
Search Results
Search Terms:Company Category= Life Sciences Company-Pharmaceutical| Acureon Pharmaceuticals 1055 Westlakes Drive Suite 300 Berwyn, PA 19312 610-727-3891 Matthew Gantz mgantz@acureonpharma.com www.acureonpharma.com Acureon is focused on building a specialty pharmaceutical company in the anti-infective and hospital products areas through acquiring undervalued pharmaceutical products and in-licensing promising products in late-clinical development. Acureon is privately held and funded by three highly regarded venture firms:, Alta Partners, Domain Associates, and NEA. |
| Adesis, Inc. 27 McCullough Drive New Castle, DE 19720 302-323-4880 Susan Baylis-Powell sbaylis-powell@adesisinc.com www.adesisinc.com Adesis is a contract research organization (CRO) supporting the pharmaceutical and biopharmaceutical industry. This industry is adopting the philosophy of outsourcing reference standards (competitor’s drugs), targets, scaffolds, building blocks and advanced intermediates. Outsourcing allows medicinal chemists to focus on design and assembly of new targets for pharmacological evaluation and streamlines the early stage drug discovery process. |
| Advanced Pharmaceutical Nanotech, LLC 91 Lukens Drive Suite E New Castle , DE 19720 302-655-6620 Lei-Shu Wu LSCWU@aol.com www.nanobiopharma.com We utilize Nano technology and cGMP pharmaceutical facilities to manufacture highly bioavailabe and less toxic iron supplements, tasty nano vitamin products, tasty and effective instant bones and joints care products, highly efficacious antacids, nano anti-aging skin care products, and natural antibacteria personal hygiene products. |
| Aptagen, LLC 250 North Main Street Jacobus, PA 17407 717-278-2436 G. Thomas Caltagirone, Ph.D. mailbox@aptagen.com www.aptagen.com Aptagen, LLC is a biotechnology company offering aptamer and aptabody custom-based services to replace antibodies in research, diagnostic platforms, drug discovery and therapeutics. |
| Aquitic Technology, Inc. 34 Dora Drive Media, PA 19063 610-566-8474 George T Sikorski, Director and Corporate Secretary georgesikorski@hotmail.com Aquitic Technology, Inc has developed and patented an innovative, energy-efficient water purification and heating system, capable of producing injectible-grade water. The system can also produce small batch pure water in pharmaceutical testing and manufacture. The firm is currently licensing the process in specific applications. |
| B. McLaughlin Associates, Inc. 1540 McDaniel Drive West Chester, PA 19380 610-430-1847 Kristen Molina Kristen@bmclaughlin.com http://www.bmclaughlin.com/ BMA is a niche provider of clinical research services based in West Chester, Pennsylvania and Phoenix, Arizona. Our services focus on Study Management, Regulatory and Financial Document Retrieval, Clinical Study Agreement/Per Patient Budget Negotiation, Informed Consent Review and Approval, Data Discrepancy Retrieval, and Regulatory Document Audits. |
| Beijing Med-Pharm Corp. 600 West Germantown Pike Suite 400 Plymouth Meeting, PA 19462 610-940-1675 F. Powell, CFO bd@beijingmedpharm.com www.beijingmedpharm.com BMP (a US public company) is a pharmaceutical marketing and distribution company in China that offers pre-market entry analysis, clinical trial management, product registration, market research, pharmaceutical distribution to hospitals, and pharmaceutical marketing to physicians, hospitals, and other healthcare providers. |
| Bristol-Myers Squibb Company Rt. 206 & Province Line Road Princeton, NJ 08540 609-252-4000 N/A web.mail@bms.com www.bms.com Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company operating in three major segments: Pharmaceuticals, Nutritionals and Other Health Care. The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business. The Nutritionals segment consists of Mead Johnson Nutritionals and the Other Health Care segment consists of ConvaTec and Medical Imaging. |
| BTG Five Tower Bridge, Suite 800 300 Barr Harbor Drive West Conshohocken, PA 19428-2998 610-278-1660 Thomas Reilly, PhD info@btgplc.com www.btgplc.com BTG in-licenses, develops and commercializes pharmaceuticals and other medical technologies. With a substantial and growing revenue stream of royalties and milestone payments from out-licensed products, BTG continues to strengthen its pipeline of preclinical and clinical development programs. BTG is active in oncology, diseases of ageing, neuroscience, drug repositioning, and medical technologies. |
| Cartesian Software 535 Cedar Drive Lafayette Hill, PA 19444 610-940-4711 Thomas Rossi thom.rossi@cartesiansoftware.com www.cartesiansoftware.com Cartesian Software was founded to improve drug safety. The company’s product, Data Lens, helps users quickly identify safety questions and use clinical trial data more efficiently. |
| Ception Therapeutics, Inc. 101 Lindenwood Drive Suite 400 Malvern, PA 19355 610-640-2940 Janet Rivello contactus@ceptiontx.com www.ceptiontx.com Ception Therapeutics is an emerging biopharmaceutical company focused on the discovery and development of novel products to address unmet medical needs. Ception was founded by experienced pharmaceutical executives in order to develop and commercialize therapeutics in areas of significant unmet medical need. |
| Chiral Technologies, Inc. 800 North Five Points Road West Chester, PA 19380 800-6-CHIRAL Lorraine Evangelista chiral@chiraltech.com www.chiraltech.com Chiral Technologies,Inc., offers a full range of chiral chromatography products and services for chiral separations including HPLC and SFC columns for analytical, semi-preparative and preparative resolutions. Our products also include bulk chiral stationary phases. These CSPs are produced under cGMP conditions for the production of chiral intermediates and APIs of single enantiomer drugs for use in clinical trials or commercial scale manufacturing. |
| CSL Behring 1020 First Avenue King of Prussia, PA 19406 610-878-4000 Roger Bentley info@cslbehring.com www.cslbehring.com CSL Behring is a global leader in the plasma protein biotherapeutics industry, dedicated to treating rare and serious diseases and passionate about improving the quality of life of patients throughout the world. |
| Cytokine PharmaSciences, Inc. Walnut Hill Plaza 150 South Warner Road, Suite 420 King of Prussia, PA 19406 610-687-1776 Dennis Willson, President & CEO dwillson@cytokinepharmasciences.com www.cytokinepharmasciences.com Cytokine PharmaSciences (CPSI) is a pharmaceutical development company focused on women's health. CPSI licenses in technologies from academia and other sources, develops products from those technologies, and outlicenses them to third parties for marketing. The company has one approved product and three in various stages of clinical development, all using its unique, controlled-release, polymer drug-delivery system. |
| DermAvance Pharmaceuticals 1055 Westlakes Drive 3rd Floor Berwyn, PA 19312 610-727-3935 Michelle Antonelli maa@dermavance.com www.dermavance.com DermAvance provides your practice with innovation, technology and exclusivity! We have recently launched several unique products to plastic surgeons and dermatologists for in-office dispensing only. Vivelif Cream, Serum and Mask (acetyl hexapeptide-3) provides a “Botox-booster” effect. Hyalogy, the first and only topical hyaluronic acid in nanotechnology, penetrates to the dermis for deep hydration. |
| Diasome Pharmaceuticals, LLC 625 Ridge Pike Building E, Suite 402 Conshohocken, PA 19428 609-923-9443 lrosenberg@diasome.com lrosenberg@diasome.com www.diasome.com Diasome Pharmaceuticals is dedicated to improving the lives of Type 1 and Type 2 Diabetes patients. Our patented nanotechnology targeted delivery systems have demonstrated preferential delivery of insulin to the liver. We have developed a proven process for advancing compounds from early stage through completion of Phase II studies faster than traditional methods at a fraction of the cost. |
| DJA Global Pharma LLC 115 Commons Ct. Chadds Ford , PA 19317 610-558-4454 Tyrah Miles office@djaglobalpharma.com www.djaglobalpharma.com DJA Global Pharma LLC, (DJA) is a US-based global drug development and regulatory consulting company for the pharmaceutical & biotechnology industries. DJA is focused on bridging the complex areas of pharmaceutical development and commercialization of pharmaceutical products in global markets. DJA has an exceptional team of global consultants with a combined experience of well over 100 years. |
| Duska Therapeutics, Inc. Two Bala Plaza Suite 300 Bala Cynwyd, PA 19004 610-660-6690 Ms. Peggy Whearty info@duskascientific.com www.duskatherapeutic.com Duska Therapeutics, Inc. engages in the development of diagnostic and therapeutic products based on the activation or blockade of P2 receptors. It develops seven drug candidates including Vagonixen™ for the treatment of chronic obstructive pulmonary disease and chronic cough; ATPace™ for the management of cardiac arrhythmias; ATPotent™ for the treatment of male infertility and Ocuprene™ for the treatment of glaucoma. |
| Endo Pharmaceuticals 100 Endo Boulevard Chadds Ford, PA 19317 610-558-9800 Information.General@Endo.com Information.General@Endo.com www.endo.com Endo Pharmaceuticals Inc. is a specialty pharmaceutical company with a broad portfolio of branded and generic prescription products focused on providing relief from pain. Endo is dedicated to improving the lives of patients through identifying, developing, and marketing innovative and differentiated products in pain management and related therapeutic areas. |
| Exaeris, Inc. 403 Gordon Drive Exton, PA 19341 484-879-2272 Stephen Beckman, President info@exaeris.com www.exaeris.com Exaeris, Inc. is a specialty pharmaceutical sales and marketing company focused on improving therapeutic outcomes by delivering valued products and services to patients and physicians. A wholly owned subsidiary of Inyx, Inc., Exaeris capitalizes on Inyx’s drug delivery technologies, development platforms, and strategic global relationships to advance medical science for patients and maximize value for our partners and stakeholders. |
| FemmePharma Global Healthcare, Inc. 37 West Avenue 2nd Floor Wayne, PA 19087 610-995-0801 Joe Plevelich info@femmepharma.com www.femmepharma.com FPGHC is a specialty pharmaceutical company committed to developing safe and effective drugs that minimize or eliminate unpleasant side effects. FPGHC’s mission is to create value by developing innovative, “woman-friendly” products in identified areas of high unmet medical need and low market penetration by existing therapeutic options. |
| Frontage Laboratories, Inc. 105 Great Valley Parkway Malvern, PA 19355 610-232-0100 Ron Connolly rconnolly@frontagelab.com www.frontagelab.com Frontage Laboratories is a leading pharmaceutical development company delivering high-quality research services to support pharmaceutical discovery, development and commercialization for large and emerging companies. We assist our partners in resolving complex product development issues through our combined experience in pharmaceutical analysis, bioanalytical testing and method development, and custom synthesis of investigational compounds. Fully compliant with cGMP/GLP regulations, we offer quality services, rapid turnaround and competitive pricing. |
| GlaxoSmithKline Consumer Healthcare One Franklin Plaza 200 North 16th Street Philadelphia, PA 19102 215-751-7209 William Koch - Consumer Healthcare Business Development william.koch@gsk.com http://us.gsk.com/medicines/consumerhealthcare.jsp A leader in the worldwide consumer healthcare market, GSK Consumer Healthcare brings oral healthcare, over-the-counter medicines and nutritional healthcare products to millions of people. |
| Immunotope, Inc. The Pennsylvania Biotechnology Center 3805 Old Easton Road Doylestown, PA 19002 215-297-8493 Edward L. Erickson eerickson@immunotope.com www.immunotope.com Immunotope is a clinical-stage biotechnology company developing immunotherapy products for the treatment of cancer and viral infections. The Company’s lead product candidate is an immunotherapeutic vaccine for advanced stage ovarian and breast cancer. Also in development are immunotherapeutics for treatment and prevention of chronic hepatitis and HIV, and autoantibody-based tests for early-stage diagnosis of ovarian and prostate cancer. |
| Jenrin Discovery 3701 Market Street Philadelphia, PA 19104 302-379-1679 John McElroy, President & CSO j.mcelroy@jenrindiscovery.com www.jenrindiscovery.com Jenrin Discovery is a privately owned emerging pharmaceutical company focused on developing more effective and safer therapeutics for the treatment of metabolic and inflammatory disorders. The company is developing orally active small molecule analogs of currently marketed drugs. This strategy significantly reduces the time and investment required to take lead molecules into preclinical and clinical testing. |
| JM Pharmaceutical Consulting 600 Markley Street Norristown, PA 19401 845 548-5206 Jeffrey B. Medwid, PhD medwidjb@aol.com I'm a recently retired Director from Wyeth. Expertise include: API and DP Stability from IND to regulatory submissions, Chairman of API Specification Committee for 15 years, PhD Organic Chemist with 5 yrs Process Chemistry and 5 yrs Discovery Medicinal Synthetic Chemist. |
| Labrepco, Inc. 101 Witmer Road Suite 700 Horsham, PA 19044 800-521-0754 Vanessa Good sales@labrepco.com www.labrepco.com LABREPCO is a distributor of capital laboratory equipment and instrumentation to the life sciences research community., which includes the “traditional” pharmaceutical, biotechnology and government research venues as well as academic, forensic and industrial research laboratories. Our products represent a broad collection of laboratory appliances and instruments that we expertly dovetail with the specific needs of our customers. |
| Lazarus Therapeutics, Inc. University City Science Center 3701 Market St., 3rd Floor Philadelphia, PA 19104 215-966-6051 Edward L. Erickson eerickson@sciencecenter.org Lazarus Therapeutics, Inc., (LTI) is a neurosciences company developing and commercializing novel therapeutic products for debilitating central nervous system (CNS) conditions, with Parkinson's disease as the initial target. The Company's strategy is to create value rapidly and reach the market through: (1) the "repurposing" and/or reformulation of existing, marketed drugs; and (2) development of "orphaned" or overlooked drug candidates for CNS indications. |
| Melior Discovery 860 Springdale Drive Suite 500 Exton, PA 19341 610-280-0636 ext 231 Michele Nathan Borek inquiries@meliordiscovery.com meliordiscovery.com Melior Discovery is dedicated to uncovering new therapeutic applications for partners' existing drugs. By utilizing the unique and highly efficient theraTRACE(sm)indications discovery platform, Melior can systematically study a single compound in multiple in vivo models, thereby evaluating potential utility in a variety of major therapeutic areas. |
| Molecular Devices 402 Boot Road Downingtown, PA 19335 800-635-5577 Mike Duvinski Mike.Duvinski@moldev.com www.MolecularDevices.com Molecular Devices Corporation is a leading supplier of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. Our systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics, proteomics and parallel chemistry by facilitating the high-throughput and cost-effective identification and evaluation of drug candidates. |
| Neuromed Pharmaceuticals, Inc. Six Tower Bridge, Suite 440 181 Washington Street Conshohocken, PA 19428 484-533-6900 Julie Jang info@neuromed.com www.neuromed.com Neuromed is a privately held biopharmaceutical company developing a new generation of chronic pain drugs with additional programs in hypertension and epilepsy. The company’s drug development programs are designed around validated clinical targets associated with large unmet markets. Neuromed is the first company to advance an oral N-type calcium channel blocker into human clinical trials. |
| Neuronyx, Inc. 1 Great Valley Parkway Suite 20 Malvern, PA 19355 610-240-4150 Mary K. Luke info@neuronyx.com www.neuronyx.com Neuronyx is developing an allogeneic human adult bone marrow-derived somatic cell product (NX-CP105) for certain diseases resulting from ischemic injury such as myocardial infarction, stroke and dermal wounds. |
| NexusPharma Inc. 253-13 Summit Square Center Langhorne, PA 19047 732-274-0010 Lutz Weber info@nexuspharm.com www.nexuspharm.com NexusPharma is developing novel drug candidates to advance cancer treatment through non-cytotoxic mechanism-based approaches. The small molecule candidates target selected cancer-promoting protein-protein interactions and inhibit critical cancer signaling networks. NexusPharma leverages its new technologies for the design and development of small molecule protein-protein interaction inhibitors with the unique know-how, cell and systems biology expertise, and insight into the complex networks of cancer-related protein interactions of the Fox Chase Cancer Center. |
| Novartis 180 Park Ave Florham Park, NJ 07932 609-610-0388 Swadesh Sharma swadesh76@yahoo.com www.novartis.com Leading Pharmaceutical company winning for the patient. |
| Novavax, Inc. 508 Lapp Road Malvern, PA 19355 484-913-1204 Robert Lee RLee@Novavax.com www.Novavax.com Novavax, Inc. is committed to leading the global fight against infectious disease by creating novel, highly potent vaccines that are safer and more effective than current preventive options. In addition, Novavax has pharmaceutical development capabilities which include micellar nanoparticle (MNP) technology, an enabling drug delivery platform. MNP technology is the basis for the development of its first FDA-approved product, Estrasorb®. |
| Particle Sciences Inc. 3894 Courtney Street Courtney 1, Suite 180 Bethlehem, PA 18017 610-861-4701 Maureen Cochran mcochran@particlesciences.com www.particlesciences.com Particle Sciences is an integrated provider of drug development services. Our focus is on emulsions, gels, particulates and drug/device combination products with specialized capabilities in topical and mucosal delivery. PSI offers a full range of formulation, analytic, and GLP/GMP manufacturing services – including sterile products. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. For more information on Particle Sciences, visit www.particlesciences.com. |
| Patients' & Consumers' Pharma 2333 West Main Street Suite 202 Lansdale, PA 19446 215-361-8030 Joseph D'Silva joe.dsilva@pandcpharma.com Patients’ & Consumers’ Pharma's mission is to be the premier company to make available customized medication therapies. We research and develop technology that fulfills our vision of “An individual patient – A unique need – A distinctive product solution.” We are an emerging start-up organization in early phase development and seek funding opportunities. |
| Pharmabridge, Inc. Pennsylvania Biotechnology Center of Bucks County 3805 Old Easton Road Doylestown, PA 18902 215-589-6350 Dr. Michael Xu michaelxu@pharmabridgegroup.com www.pharmabridgegroup.com Pharmabridge, Inc. provides chemistry support service for pharmaceutical and biotechnology companies. Our services range from drug discovery services, custom synthesis and catalog chemicals. |
| Prism Pharmaceuticals, Inc. 1150 First Ave. Suite 1050 King of Prussia, PA 19406 610-265-7710 Stan Musial, CFO smusial@prismpharma.com www.prismpharma.com Prism Pharmaceuticals Inc. is a specialty pharmaceutical company that commercializes branded prescription products for acute care indications. The Company is led by Dr. Warren Cooper, a former drug development and general management executive at Merck Research Laboratories, AstraMerck and AstraZeneca. Prism is establishing a robust product portfolio through aggressive licensing and acquisition of commercially branded products and compounds in late-stage development. |
| Progenra, Inc. Great Valley Corpoprate Center 271A Great Valley Parkway Malvern, PA 19355 610-644-6974 Michael R Mattern mattern@progenra.com www.progenra.com Progenra Inc. is a biotechnology company committed to drug discovery utilizing the ubiquitin and ubiquitin-like protein pathways. Through its platform for high-throughput screening against novel drug targets in these pathways, Progenra’s goal is to develop medicines to treat cancer, muscle wasting, Parkinson’s, and other diseases. Progenra is currently expanding its discovery platform to include every viable target in these pathways. |
| Promedior, Inc. 5 Great Valley Parkway Suite 300 Malvern, PA 19355 610-560-1435 Timothy J. Pelura, Ph.D. tpelura@promedior.com www.promedior.com Promedior, Inc. is a product-focused biopharmaceutical company developing novel therapeutics for the treatment of fibrotic disorders and diseases. Promedior has license to novel biology and is developing innovative new compounds and therapies based on that biology. With leadership and advisors on the cutting edge of fibrosis research, Promedior is positioned to be a leader in the development of new therapies for fibrotic disorders and diseases. |
| Protez Pharmaceuticals 30 Spring Mill Drive Malvern, PA 19355 610-695-0200 Karen Jurasits jurasits@protez.com www.protez.com Discovers and develops hospital antibiotics for difficult-to-treat infections |
| Schering-Plough Corporation 2000 Galloping Hill Road Kenilworth, NJ 07033 908-298-6720 Michael J. DuBois michael.dubois@spcorp.com www.schering-plough.com Schering-Plough is a global, science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its approximately 33,500 people around the world. |
| Scott Medical Products 6141 Easton Road P.O. Box 310 Plumsteadville, PA 18949-0310 215-766-7407 David J Gibboni, PhD, Business Devel Mgr dgibboni@scottgas.com www.scottgas.com Scott Medical Products provides pure gases and mixtures as Class I, II, and III device gases, therapeutic gases, and active pharmaceutical ingredients for calibration of medical devices in anesthesia monitoring, blood gas monitoring and pulmonary testing. We are an exclusive supplier for non-gas fluorinating reagents and fluorinated compounds for pharmaceutical applications. We are FDA-registered and ISO 13485 certified. |
| Secant Pharma 907 Edgewood Lane Langhorne, PA 19053 215-741-1165 Dale M. Lombardi dlombardi@secantpharma.com www.secantpharma.com Secant Pharma is a U.S.-based privately held specialty pharmaceutical company that operates internationally and is devoted to the development and commercialization of innovative, differentiated, value-generating therapeutics for market segments with unmet medical needs. The primary focus of the company at this time is to fully capitalize on the intellectual property that it owns. |
| Shire Pharmaceuticals 725 Chesterbrook Boulevard Wayne, PA 19087 484-595-8110 Barbara Deptula businessdevelopment@shire.com www.shire.com Shire is a leading specialty pharmaceutical company that focuses on meeting the needs of the specialist physician. Shire centers its business ADHD, human genetic therapies, gastrointestinal (GI), and renal diseases. Shire has operations in the world’s key pharmaceutical markets including the US, Europe, Canada and South America. |
| Simmons Consulting 19 Stirrup Run Newark, DE 19711 302-379-1876 Kirk Simmons SimmonsConsulting@gmail.com http://www.linkedin.com/in/kirksimmons Simmons Consulting provides consulting services in the area of cheminformatics, screening library design, design of experiments (DOE), predictive modeling and analysis of high-throughput experimental results. Extensive experience in organic chemistry, lead optimization strategies, and physical property predictions of small organics (logS, logVp and pKa). |
| Skanska USA Building, Inc. 516 East Township Line Road Suite 100 Blue Bell, PA 19422 267-470-1000 Ron Jones ron.jones@skanskausa.com www.skanskausa.com Skanska is a leader in providing construction services to clients in the pharmaceutical and biotechnology manufacturing/process industries. We have the capabilities to construct, renovate and expand facilities from 1,000 square feet to more than 300,000 square feet. We also specialize in handling projects in Puerto Rico for many of our clients, with whom we’ve developed long-term relationships – making us a leader in repeat business. |
| SSPCC, Inc. 21 Pin Oaks Drive Suite 101 Phoenixville, PA 19460 610-933-9689 Caroline Bell cpbell@sspcc.com sspcc.com Consultant, Preclinical Development and IND Strategy. 25+ years pharmaceutical R&D. Toxicology and Safety Pharmacology - CRO Management (protocol, in-life, report, regulatory summary documents), facility audit, design/implementation of in-house capability. Risk/safety profiles assessment, IND/NDA submissions. State-of-the-art Safety Pharmacology technologies, GLP, Investigative studies Phase II-IV, preclinical toxicological issues, regulatory reports, executive operations management. Board of Directors Safety Pharmacology Society. Full resume www.sspcc.com |
| TDM Pharmaceutical Research, LLC 100 Biddle Ave. Suite 202 Newark, DE 19702 302-832-1008 Dana A Janssen Info@TDMRXResearch.com www.TDMRXResearch.com TDM Pharmaceutical Research, LLC is a well established and highly productive contract research organization (CRO), offering a variety of bioanalytical discovery, development, and clinical support for the global pharmaceutical industry. TDM is a full service GLP and GCP compliant laboratory with CLIA certification. We specialize in the areas of bioanalysis, method development, and pharmacokinetics, providing a customized approach to each client and their projects. We focus on your priorities, while maintaining rapid data turn around, accuracy, and quality that are critical to your business. |
| TetraLogic Pharmaceuticals Corporation 343 Phoenixville Pike Malvern, PA 19355 610-889-9900 Amy Greene agreene@tetralogicpharma.com www.tetralogicpharma.com TetraLogic Pharmaceuticals specializes in oncology therapeutics. The Company’s lead program is developing a novel class of small molecules that enable cancer cells to die by apoptosis, or programmed cell death. TetraLogic has raised about $50 million since 2004 and its investors include PA Early Stage, Quaker BioVentures, Healthcare Ventures, Latterell Venture Partners, the Vertical Group and Amgen Ventures. |
| The Business/Technology Interface, LLC 21 Tenby Chase Voorhees, NJ 08043 856-753-7650 Richard S. Woodward rswoodward@net-gate.com The Business/Technology Interface, LLC provides business strategy, business development and technical operations support to early-stage companies in the pharma, biotech and specialty chemicals fields. These services have been characterized as a "COO for hire." |
| The ORION Group 3809 Violet Dr Philadelphia, PA 19154 267.825.1287 Matthew J. O'Brien, Ph.D. mobrien12@aol.com Experienced in quality and regulatory matters with almost 40 years experience in these areas (>30 NDAs and 120 INDs). Significant experience with stability protocols, specifications and methods validation. Also CTD, laboratory management and product development. |
| Topaz Pharmaceuticals LLC 130 Greenwwod Ave. Jenkintown, PA 19046 215 990 5145 Nick Spring nick_spring@topazpharma.com www.topazpharma.com The mission of Topaz Pharmaceuticals LLC is to provide the field of pediatrics with innovative products that will facilitate the treatment of common pediatric diseases and conditions, especially those that occur in children from 0 -13 years of age. The initial focus of Topaz Pharmaceuticals LLC will be on head lice control products. |
| Wyeth Pharmaceuticals 500 Arcola Rd. Collegeville, PA 19426 484-865-5000 Patrick Plues pluesp@wyeth.com www.wyeth.com Wyeth is a global leader in prescription pharmaceuticals, non-prescription consumer health products, and pharmaceuticals for animal health. Wyeth's product portfolio includes innovative treatments across a range of therapeutic areas. Wyeth's resources include 50,000 employees, manufacturing facilities on four continents, and a technology base encompassing small molecules, biopharmaceuticals, genetic engineering that will provide the next wave of innovative therapies and vaccines. |
| YM BioSciences, Inc. 701 Lee Road Suite 200 Wayne, PA 19087 610-560-0600 Gary Floyd ir@ymbiosciences.com www.ymbiosciences.com YM BioSciences is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. Late-stage products include nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR); and AeroLEF™, a unique, inhaled-delivery composition of free and liposome-encapsulated fentanyl, in development for the treatment of moderate to severe pain, including cancer pain. |